World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 108 5867 5511 332 318 695 73630

Freek W.A. Verheugt publications per year

The chart shows the history of publications by Freek W.A. Verheugt between 1981 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Freek W.A. Verheugt published across 45 years, from 1981 to 2025, averaging 15.8 papers a year. Output peaked at 47 publications in 2007. 5 of the 709 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1981 to 2025. Vertical axis: number of publications, 0 to 47. Peak 47 publications in 2007. 1981: 2 publications 1982: 0 publications 1983: 1 publication 1984: 2 publications 1985: 0 publications 1986: 4 publications 1987: 6 publications 1988: 6 publications 1989: 4 publications 1990: 4 publications 1991: 6 publications 1992: 3 publications 1993: 6 publications 1994: 1 publication 1995: 3 publications 1996: 19 publications 1997: 18 publications 1998: 7 publications 1999: 14 publications 2000: 12 publications 2001: 20 publications 2002: 29 publications 2003: 37 publications 2004: 26 publications 2005: 21 publications 2006: 24 publications 2007: 47 publications 2008: 34 publications 2009: 25 publications 2010: 19 publications 2011: 26 publications 2012: 28 publications 2013: 39 publications 2014: 17 publications 2015: 23 publications 2016: 20 publications 2017: 32 publications 2018: 36 publications 2019: 30 publications 2020: 20 publications 2021: 18 publications 2022: 4 publications 2023: 11 publications 2024: 3 publications 2025: 2 publications
1981 2025

709 publications in total across all disciplines

View publications per year as a table
Freek W.A. Verheugt: publications per year, 1981 to 2025
Year Publications
1981 2
1982 0
1983 1
1984 2
1985 0
1986 4
1987 6
1988 6
1989 4
1990 4
1991 6
1992 3
1993 6
1994 1
1995 3
1996 19
1997 18
1998 7
1999 14
2000 12
2001 20
2002 29
2003 37
2004 26
2005 21
2006 24
2007 47
2008 34
2009 25
2010 19
2011 26
2012 28
2013 39
2014 17
2015 23
2016 20
2017 32
2018 36
2019 30
2020 20
2021 18
2022 4
2023 11
2024 3
2025 2
Total 709
Download as CSV

Freek W.A. Verheugt publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Freek W.A. Verheugt sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 681–700 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 695 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336 695
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Freek W.A. Verheugt D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Freek W.A. Verheugt sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 108–109 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445 108
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Freek W.A. Verheugt is affiliated with the University Medical Centre Mannheim in Germany. Their research primarily spans the field of Medicine, with 108 publications focused within this area.

Their work emphasizes Cardiology and Cardiovascular Medicine, contributing 67 publications in this subfield. Other notable subfields include Internal Medicine, Surgery, Economics and Econometrics, and Psychiatry and Mental Health.

Main research topics explored by Verheugt include:

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Musculoskeletal Pain and Rehabilitation

Freek W.A. Verheugt has contributed to several frequent publication venues, with a strong presence in the European Heart Journal, where they have published six papers. Other venues include Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Healthcare, and BMJ Open.

Prominent coauthors collaborating with Verheugt include:

  • Karen S. Pieper
  • Sylvia Haas
  • A. John Camm
  • Jean-Pierre Bassand
  • Keith A.A. Fox

Recent papers authored or coauthored by Verheugt cover topics related to atrial fibrillation, antithrombotic regimens, extracorporeal membrane oxygenation, and oral anticoagulants combined with antiplatelets. Notable works include:

  • Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention, 2020, JAMA Cardiology
  • Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial, 2021, EuroIntervention
  • Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry, 2021, Blood Advances
  • Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry, 2021, Journal of Thrombosis and Haemostasis
  • Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation, 2020, JAMA Network Open

Best Publications

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • 2012 focused update of the ESC Guidelines for the management of atrial fibrillation

    A. John Camm;Gregory Y.H. Lip

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008

    John Camm;Veronica Dean;Jose Luis Zamorano;Perry M. Elliott

  • Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

    Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  • Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

    Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Jean-Pierre Bassand

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  • Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

    Willem J. M. Dewilde;Tom Oirbans;Freek W. A. Verheugt;Johannes C. Kelder

  • Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Diego Ardissino;Amadeo Betriu;Dennis V. Cokkinos

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

    Stephen D. Wiviott;Eugene Braunwald;Dominick J. Angiolillo;Simha Meisel

  • Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.

    Jochem W. van Werkum;Antonius A. Heestermans;A. Carla Zomer;Johannes C. Kelder

  • Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm

  • Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

    Frans Van de Werf

  • Early Invasive Versus Selectively Invasive Management for Acute Coronary Syndromes

    Robbert J. de Winter;Fons Windhausen;Jan Hein Cornel;Peter H.J.M. Dunselman

  • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

    Michael E. Farkouh;Howard Kirshner;Robert A. Harrington;Sean Ruland

  • Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

    Investigators;John H Alexander;Richard C Becker

  • Gender differences in the management and clinical outcome of stable angina.

    Caroline Daly;Felicity Clemens;Jose L. Lopez Sendon;Luigi Tavazzi

  • Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome Results From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial

    Benjamin M. Scirica;David A. Morrow;Hanoch Hod;Sabina A. Murphy

  • Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial.

    Robert F. Van Es;Jan J. C. Jonker;Freek W. A. Verheugt;Jaap W. Deckers;Jaap W. Deckers

Frequent Co-Authors

Gregory Y.H. Lip
Gregory Y.H. Lip University of Liverpool
Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Lars Wallentin
Lars Wallentin Uppsala University
Christopher B. Granger
Christopher B. Granger Duke University
Jurriën M. ten Berg
Jurriën M. ten Berg Erasmus University Rotterdam
Kurt Huber
Kurt Huber Sigmund Freud University Vienna
John H. Alexander
John H. Alexander Duke University
Renato D. Lopes
Renato D. Lopes Duke University
Shinya Goto
Shinya Goto Tokai University
Raffaele De Caterina
Raffaele De Caterina University of Pisa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is just one of many ways to build a rewarding career in healthcare. For those looking for flexible learning options, online degrees in related fields offer a convenient path forward. For example, pursuing a health administration degree online can prepare you for leadership roles behind the scenes at clinics, hospitals, or insurance companies.

If your career goals include advanced management roles, consider the growing number of affordable online MHA programs. These graduate degrees focus on the business and policy sides of healthcare, equipping students with the skills to improve patient outcomes on a larger scale.

Some healthcare professionals take the clinical route with advanced nursing, and flexible MSN to DNP programs online can help you reach the highest levels of nursing practice. Pharmacists, on the other hand, can upgrade their qualifications with an online pharmacy degree, opening doors to clinical, research, or policy careers.

These online programs make it possible to transition or advance within the dynamic healthcare industry, often while maintaining professional and personal commitments.

Best Scientists Citing Freek W.A. Verheugt

Trending Scientists

Recently Published Articles